As the UKHSA issues new essential health guidance for travellers going abroad, a leading testing expert warns of the increasing risks of European holidays.
Kronos Bio swivels focus to multiple melanoma
Share this article Cancer patient in hospital bed. Kronos Bio is discontinuing the development of its AML therapy laanraplenib. Credit: E+ via Getty Images Kronos